Point of care whole blood glucose testing equipment and supplies
Ended Awarded Last action
- Contract number
- 36C25624N0089
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 16
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $22,322
Award facts
- Contract value 100% obligated
- $22,322.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$21,887 | |
| Original award | $44,209 |
About this award
Roche Diagnostics Corporation received a $22,322.28 firm fixed-price Blanket Purchase Agreement call for point-of-care whole blood glucose testing equipment and supplies from Veterans Integrated Service Network 16 (VISN 16), a civilian healthcare entity within the Department of Veterans Affairs. The contract, awarded October 1, 2023, with completion by September 30, 2024, will be performed at the company's facility in Castleton, Indiana. This award was made without set-aside designation under the parent In Vitro Diagnostics, Reagents, Test (FSS-65-VII) General Services Administration schedule, reflecting open competition in the federal marketplace.
Roche Diagnostics Corporation is a foreign-owned, for-profit manufacturer specializing in in vitro diagnostics and laboratory instruments, maintaining an extensive federal contracting presence across the Department of Veterans Affairs, Defense Health Agency, and other civilian healthcare entities. The company supplies diagnostic technologies ranging from point-of-care testing devices to advanced molecular diagnostic analyzers. This BPA call represents one component of Roche's broader portfolio supporting federal healthcare agencies, including multiple active indefinite delivery contracts and blanket purchase agreements with various VISNs and Defense Health Agency entities valued at millions of dollars and extending through 2030, demonstrating sustained demand for the company's diagnostic capabilities across the federal healthcare system.
Quick answers
Who was awarded contract 36C25624N0089?
36C25624N0089 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 16 (Veterans Health Administration) on October 1, 2023.
How much is contract 36C25624N0089 worth?
The government has obligated $22,322 on 36C25624N0089.
Is contract 36C25624N0089 an order under another contract?
Yes. 36C25624N0089 is a BPA call under V797P5279B-36C25621A0023, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25624N0089 competed?
The extent of competition for 36C25624N0089 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award